首页> 外国专利> Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis.

Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis.

机译：软骨寡聚基质蛋白在类风湿关节炎治疗中的用途。

页面导航

摘要
著录项
相似文献

摘要

B "USE OF OLIGOMERIC CARTILAGE MATRIX PROTEIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS" D. The invention relates to the use of a cartilage matrix protein (COMP) or fragments or analogues thereof, for the manufacture of a pharmaceutical composition for the prevention or treatment of arthritic conditions, in which the pharmaceutical composition is administered in an amount effective in order to avoid or treat the arthritic condition.

机译：“使用寡聚软骨基质蛋白治疗类风湿关节炎” 。本发明涉及软骨基质蛋白（COMP）或其片段或类似物在制备用于预防或治疗关节炎病症的药物组合物中的用途，其中以有效量施用所述药物组合物以避免或治疗关节炎。 展开▼

著录项

公开/公告号BR9808591A

专利类型

公开/公告日2000-05-23

原文格式PDF

申请/专利权人 ASTRA AKTIEBOLAG;E);
展开▼

申请/专利号BR19989808591

发明设计人 HEINEGARD DICK;LORENTZEN JOHNNY;KLARESKOG LARS;
展开▼

申请日1998-04-14

分类号A61K38/17;C07K14/47;

国家 BR

入库时间 2022-08-22 01:57:11

相似文献

专利

外文文献

中文文献

1. 桂枝总酚酸在制备治疗类风湿关节炎药物中的用途 [P] . 中国专利： CN113967228A . 2022-01-25

2. 光甘草定在制备治疗类风湿关节炎的药物中的用途 [P] . 中国专利： CN113546071A . 2021-10-26

3. USE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS [P] . 欧洲知识产权局专利： EP1019078B1 . 2003-07-23

机译：软骨低聚基质蛋白在类风湿关节炎的治疗中的应用

4. Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis [P] . AU746221B2 . 2002-04-18

机译：软骨寡聚基质蛋白在类风湿关节炎治疗中的应用

5. USE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS [P] . HU0002231A3 . 2002-09-30

机译：软骨低聚基质蛋白在类风湿关节炎的治疗中的应用

1. Association between serum cartilage oligomeric matrix protein and coronary artery calcification in maintenance hemodialysis patients [J] . Lahati HA, Jun-Bao SHI, Hai-Yi YU, 老年心脏病学杂志（英文版） . 2020,第002期

2. Altered serum level of cartilage oligomeric matrix protein and its association with coronary calcification in patients with coronary heart disease [J] . Fang-Fang WANG, Lahati HA, Hai-Yi YU, 老年心脏病学杂志（英文版） . 2017,第002期

3. Cartilage oligomeric matrix protein enhances the vascularization of acellular nerves [J] . Wei-ling Cui, Long-hai Qiu, Jia-yan Lian, 中国神经再生研究（英文版） . 2016,第003期

4. Effect of Excipients on Lag Time of Press Coated Tablets in Pulsatile Drug Delivery For The Treatment of Rheumatoid Arthritis. [C] . Deepali V. Kaduskar, Bala Prabhakar Annual meeting exposition of the Controlled Release Society . 2010

5. Multicyclic Grafted Peptides Derived from CD2 Protein to Inhibit Protein-Protein Interaction Between CD2 And CD58 Costimulatorymolecules: Implications in Rheumatoid Arthritis. [D] . Sable, Rushikesh V. 2017

6. Joint remodeling outcome of serum levels of Dickkopf-1 (DKK1) cartilage oligomeric matrix protein (COMP) and C-telopeptide of type II collagen (CTXII) in rheumatoid arthritis [O] . NAGLAA K. IDRISS, RANIA M. GAMAL, MARWA A. GABER, 2020

7. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study [O] . P. Roux-Lombard 2001

1. Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication [J] . Kristofer ANDréasson ,G?ran J?nsson ,Roger HesselstrAND . 世界肝病学杂志：英文版（电子版） . 2019,第3期

2. Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma [J] . Gary L Norman ,Nikolaos K Gatselis ,Zakera Shums . 世界肝病学杂志：英文版（电子版） . 2015,第14期

3. 类风湿关节炎的中医辨证治疗中医药治疗类风湿关节炎思路和方法探讨 [C] . 何夏秀 ,马晓晶 ,冯兴华 . 中华中医药学会风湿病分会2010年学术会议 . 2010

4. 血清软骨寡聚基质蛋白在类风湿关节炎患者中的意义 [A] . 刘金婷 . 2010